Skip to content

300759.SZ

Pharmaron Beijing Co., Ltd.

SZSE · Healthcare · M 科研服务 · CN

CNY 39.49
+6.01%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue16.0B14.1B12.3B11.5B10.3B
Cost of Revenue10.7B9.2B8.1B7.4B6.5B
Gross Profit5.3B4.9B4.2B4.1B3.8B
Operating Expenses
R&D Expense623.5M576.0M469.3M448.3M282.3M
SG&A Expense505.4M————
General & Admin Expense854.0M1.7B1.6B1.6B1.5B
Selling & Marketing Expense110.6M306.5M258.4M252.8M230.1M
Other Expenses706.7M————
Total Operating Expenses3.1B2.9B2.6B2.4B2.3B
Cost and Expenses13.7B12.1B10.6B9.8B8.8B
Operating Income (EBIT)2.2B1.9B2.1B1.8B1.7B
Non-Operating
Interest Income38.7M————
Interest Expense99.6M————
Net Interest Income(60.9M)————
Other Non-Op Income/Expense(73.4M)————
Non-Operating Income (excl Interest)—————
EBT (Pre-Tax Income)2.1B1.9B2.1B1.8B1.7B
Income Tax Expense422.6M357.5M377.1M256.1M314.3M
Bottom Line
Net Income1.8B1.7B1.8B1.6B1.4B
Earnings from Cont. Ops1.7B1.6B1.7B1.6B1.4B
Earnings from Discont. Ops—————
Bottom Line Net Income1.8B1.7B1.8B1.6B1.4B
Per Share
Basic EPSCN¥0.99CN¥0.94CN¥1.01CN¥0.90CN¥0.78
Diluted EPSCN¥0.99CN¥0.94CN¥1.01CN¥0.90CN¥0.77
Revenue Per ShareCN¥8.77CN¥8.00CN¥6.94CN¥6.51CN¥5.79
Shares
Basic Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Diluted Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Profitability Metrics
EBITDA1.6B3.0B3.1B2.7B2.3B
D&A359.7M1.1B974.9M822.6M630.6M
EBIT1.2B————

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026